MAIA Biotechnology Inc. (MAIA)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $61.75M
Last updated: Nov 17, 2026 at 4:41 PM ET
MAIA Biotechnology Inc. (MAIA) Statistics
MAIA Biotechnology (MAIA) has a market cap of $61.75M and an enterprise value of $40.41M. Its share count is up 83.32% from a year earlier. It holds $21.34M more cash than debt, 34.56% of its market cap.
Total Valuation
Enterprise value is 34.56% below the market cap, as cash exceeds debt.
| Market Cap | $61.75M |
|---|---|
| Enterprise Value | $40.41M |
| Latest price (Nov 17, 2026) | $1.24 |
Key Dates
The next earnings report is expected on Mar 22, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is up 19.23% over 52 weeks and trades 5.08% above its 50-day average.
| Beta (1Y) | 1.50 |
|---|---|
| 52-Week Change | +19.23% |
| 1-Month Change | +15.89% |
| 3-Month Change | -10.79% |
| 6-Month Change | +0.81% |
| Total Return (1Y) | +19.23% |
| Total Return (3Y CAGR) | +0.82% |
| Return vs SPY (1Y) | +11.21% |
| Max Drawdown (1Y) | -66.10% |
| Max Drawdown (3Y) | -82.92% |
| Sharpe Ratio (1Y) | 0.23 |
| Correlation with SPY (1Y) | 0.23 |
| 50-Day Average | $1.18 |
| 200-Day Average | $1.38 |
| 52-Week Range | $0.87 to $3.19 |
| RSI (14 Days) | 61.0 |
| Average Volume (20 Days) | 330.74K |
Financial Position
Current assets cover 3.41x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 3.41x |
|---|---|
| Quick Ratio | 3.41x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -171.24% and return on assets is -113.66% over the last 12 months.
| Return on Equity (ROE) | -171.24% |
|---|---|
| Return on Assets (ROA) | -113.66% |
Scores
MAIA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$27.61M |
| Pretax Income | -$25.12M |
| Net Income | -$25.12M |
| Reported EPS (TTM) | -$0.53 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 66.38% of the $22.10M in total assets.
| Cash and Equivalents | $21.34M |
|---|---|
| Total Debt | $0 |
| Net Cash | $21.34M |
| Net Cash Per Share | $0.35 |
| Working Capital | $15.62M |
| Shareholder Equity | $14.67M |
| Book Value Per Share | $0.24 |
| Total Assets | $22.10M |
| Total Liabilities | $7.43M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$25.39M |
|---|---|
| FCF Per Share | -$0.41 |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | +62.22% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | +62.22% |
Dividends and Yields
MAIA does not pay a dividend.
| Buyback Yield | -47.53% |
|---|---|
| Shareholder Yield | -47.53% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About MAIA
What is MAIA's market cap?
MAIA Biotechnology has a market cap of $61.75M. Its enterprise value, which adds debt and subtracts cash, is $40.41M.
How many shares of MAIA are outstanding?
MAIA Biotechnology has 60.86M shares outstanding. The count is up 83.32% from a year earlier.
Does MAIA pay a dividend?
No. MAIA Biotechnology does not pay a dividend.
How much debt does MAIA have?
MAIA Biotechnology has $0 of total debt and $21.34M of cash and equivalents, a net cash position of $21.34M.
MAIA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors